The hedgehog signalling pathway is abnormally activated in most basal cell carcinomas, in one-third or more medulloblastomas, and has been implicated in several other types of cancer. Rubin and de Sauvage discuss the therapeutic opportunities presented by recent insights into this pathway, and the compounds currently in development.
- Lee L. Rubin
- Frederic J. de Sauvage
